STOCK TITAN

Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Quantum-Si (Nasdaq: QSI), The Protein Sequencing Company™, has announced its participation in an upcoming DNAnexus webinar focused on proteomics in multi-omics research. The virtual event, scheduled for March 25, 2025, at 8 a.m. PT/11 a.m. ET, will explore how integrating proteomics data with other omics datasets drives new discoveries in disease research, including cancer.

Key speakers include Meredith Carpenter, PhD from Quantum-Si, Cindy Lawley, PhD from Olink, Thermo Fisher Scientific, and Theresa Wohlever from DNAnexus. The webinar will cover:

  • The growing impact of proteomics in multi-omics analysis
  • Applications for cancer and other disease research
  • Technologies and strategies for large-scale discovery and data analysis
  • Tools for orthogonal validation of proteins of interest

Quantum-Si (Nasdaq: QSI), La Società di Sequenziamento delle Proteine™, ha annunciato la sua partecipazione a un prossimo webinar di DNAnexus incentrato sulla proteomica nella ricerca multi-omica. L'evento virtuale, programmato per 25 marzo 2025, alle 8:00 PT/11:00 ET, esplorerà come l'integrazione dei dati proteomici con altri set di dati omici possa portare a nuove scoperte nella ricerca sulle malattie, incluso il cancro.

I relatori principali includono Meredith Carpenter, PhD di Quantum-Si, Cindy Lawley, PhD di Olink, Thermo Fisher Scientific, e Theresa Wohlever di DNAnexus. Il webinar tratterà:

  • L'impatto crescente della proteomica nell'analisi multi-omica
  • Applicazioni per la ricerca sul cancro e altre malattie
  • Tecnologie e strategie per la scoperta su larga scala e l'analisi dei dati
  • Strumenti per la validazione ortogonale delle proteine di interesse

Quantum-Si (Nasdaq: QSI), La Compañía de Secuenciación de Proteínas™, ha anunciado su participación en un próximo webinar de DNAnexus centrado en la proteómica en la investigación multi-ómica. El evento virtual, programado para 25 de marzo de 2025, a las 8 a.m. PT/11 a.m. ET, explorará cómo la integración de datos proteómicos con otros conjuntos de datos ómicos impulsa nuevos descubrimientos en la investigación de enfermedades, incluido el cáncer.

Los ponentes principales incluyen a Meredith Carpenter, PhD de Quantum-Si, Cindy Lawley, PhD de Olink, Thermo Fisher Scientific, y Theresa Wohlever de DNAnexus. El webinar cubrirá:

  • El creciente impacto de la proteómica en el análisis multi-ómico
  • Aplicaciones para la investigación del cáncer y otras enfermedades
  • Tecnologías y estrategias para el descubrimiento y análisis de datos a gran escala
  • Herramientas para la validación ortogonal de proteínas de interés

Quantum-Si (Nasdaq: QSI), 단백질 서열 분석 회사™, 는 다중 오믹스 연구에서 단백질체학에 중점을 둔 DNAnexus 웨비나에 참여할 것이라고 발표했습니다. 2025년 3월 25일 오전 8시 PT/오후 11시 ET에 예정된 이 가상 이벤트는 단백질체학 데이터를 다른 오믹스 데이터 세트와 통합하여 질병 연구, 특히 암 연구에서 새로운 발견을 이끌어내는 방법을 탐구할 것입니다.

주요 연사로는 Quantum-Si의 Meredith Carpenter, PhD, Olink, Thermo Fisher Scientific의 Cindy Lawley, PhD, 그리고 DNAnexus의 Theresa Wohlever가 있습니다. 웨비나는 다음과 같은 내용을 다룰 것입니다:

  • 다중 오믹스 분석에서 단백질체학의 증가하는 영향
  • 암 및 기타 질병 연구를 위한 응용 프로그램
  • 대규모 발견 및 데이터 분석을 위한 기술과 전략
  • 관심 있는 단백질의 정량적 검증을 위한 도구

Quantum-Si (Nasdaq: QSI), La Société de Séquençage des Protéines™, a annoncé sa participation à un prochain webinaire de DNAnexus axé sur la protéomique dans la recherche multi-omique. L'événement virtuel, prévu pour le 25 mars 2025, à 8h PT/11h ET, explorera comment l'intégration des données protéomiques avec d'autres ensembles de données omiques peut conduire à de nouvelles découvertes dans la recherche sur les maladies, y compris le cancer.

Les intervenants principaux comprennent Meredith Carpenter, PhD de Quantum-Si, Cindy Lawley, PhD d'Olink, Thermo Fisher Scientific, et Theresa Wohlever de DNAnexus. Le webinaire couvrira :

  • L'impact croissant de la protéomique dans l'analyse multi-omique
  • Applications pour la recherche sur le cancer et d'autres maladies
  • Technologies et stratégies pour la découverte à grande échelle et l'analyse de données
  • Outils pour la validation orthogonale des protéines d'intérêt

Quantum-Si (Nasdaq: QSI), Das Unternehmen für Proteinsequenzierung™, hat seine Teilnahme an einem bevorstehenden DNAnexus-Webinar angekündigt, das sich auf Proteomik in der Multi-Omics-Forschung konzentriert. Die virtuelle Veranstaltung, die für 25. März 2025, 8 Uhr PT/11 Uhr ET geplant ist, wird untersuchen, wie die Integration von Proteomik-Daten mit anderen Omics-Datensätzen neue Entdeckungen in der Krankheitsforschung, einschließlich Krebs, vorantreibt.

Zu den Hauptrednern gehören Meredith Carpenter, PhD von Quantum-Si, Cindy Lawley, PhD von Olink, Thermo Fisher Scientific, und Theresa Wohlever von DNAnexus. Das Webinar wird folgende Themen behandeln:

  • Die wachsende Bedeutung der Proteomik in der Multi-Omics-Analyse
  • Anwendungen für Krebs- und andere Krankheitsforschung
  • Technologien und Strategien für groß angelegte Entdeckungen und Datenanalysen
  • Werkzeuge zur orthogonalen Validierung von interessierenden Proteinen
Positive
  • None.
Negative
  • None.

Validate multi-omics findings at the single-molecule level with Next-Gen Protein Sequencing™

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company, announces participation in an upcoming DNAnexus webinar focused on the role of proteomics in multi-omics research. This discussion will explore how the integration of proteomics data with other omics datasets is driving new discoveries in disease research, including cancer.

When: March 25, 2025, at 8 a.m. PT/11 a.m. ET

Attendees will learn about:

  • The growing impact of proteomics in multi-omics analysis
  • Applications for cancer and other disease research
  • Technologies and strategies for large-scale discovery and data analysis
  • Tools for orthogonal validation of proteins of interest

WHO: Featured speakers include:

  • Meredith Carpenter, PhD, Head of Scientific Affairs, Quantum-Si
  • Cindy Lawley, PhD, Sr. Director, Population Health Proteomic Sciences, Olink, Thermo Fisher Scientific
  • Theresa Wohlever, Sr. Bioinformatics Scientist, DNAnexus

WHERE: Virtual event – registration required.

HOW: To register, please complete the registration form. A confirmation email will be sent upon registration.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® line of instruments enables Next-Gen Protein Sequencing that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

Investor Contact

Jeff Keyes

Chief Financial Officer

ir@quantum-si.com

Media Contact

Katherine Atkinson

SVP, Commercial Marketing

media@quantum-si.com

Source: Quantum-Si Incorporated

FAQ

When is Quantum-Si (QSI) hosting the DNAnexus webinar on proteomics research?

The webinar is scheduled for March 25, 2025, at 8 a.m. PT/11 a.m. ET.

What topics will be covered in the QSI and DNAnexus proteomics webinar?

The webinar will cover proteomics in multi-omics analysis, cancer research applications, large-scale discovery strategies, and protein validation tools.

Who are the key speakers at the Quantum-Si (QSI) proteomics webinar?

Key speakers include Meredith Carpenter from Quantum-Si, Cindy Lawley from Olink/Thermo Fisher Scientific, and Theresa Wohlever from DNAnexus.

How can investors attend the Quantum-Si (QSI) DNAnexus proteomics webinar?

The virtual event requires registration through a registration form, after which attendees will receive a confirmation email.

What is the focus of Quantum-Si's (QSI) collaboration with DNAnexus?

The collaboration focuses on exploring proteomics integration with multi-omics datasets for disease research and cancer discoveries using next-gen protein sequencing.
Quantum-Si Incorporated

NASDAQ:QSI

QSI Rankings

QSI Latest News

QSI Stock Data

219.77M
138.43M
14.83%
29.05%
9.65%
Medical Devices
Measuring & Controlling Devices, Nec
Link
United States
BRANFORD